Von Hoff D - Search Results

1

A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.

Coveler AL, Ko AH, Catenacci DV, Von Hoff D, Becerra C, Whiting NC, Yang J, Wolpin B. Coveler AL, et al. Among authors: von hoff d. Invest New Drugs. 2016 Jun;34(3):319-28. doi: 10.1007/s10637-016-0343-x. Epub 2016 Mar 18. Invest New Drugs. 2016. PMID: 26994014 Clinical Trial.

2

Response of metastatic adenoid cystic carcinoma and Merkel cell tumor to high-dose melphalan with autologous bone marrow transplantation.

Slichenmyer WJ, LeMaistre CF, Von Hoff DD. Slichenmyer WJ, et al. Among authors: von hoff dd. Invest New Drugs. 1992 Apr;10(1):45-8. doi: 10.1007/BF01275481. Invest New Drugs. 1992. PMID: 1318872

3

Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units.

Von Hoff DD, Marshall MH, Heimbrook DC, Stirdivant SM, Ahern JD, Herbert WK, Maigetter RZ, Oliff A. Von Hoff DD, et al. Invest New Drugs. 1992 Apr;10(1):17-22. doi: 10.1007/BF01275472. Invest New Drugs. 1992. PMID: 1607249

4

Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Gasparini G, Dal Fior S, Pozza F, Panizzoni GA, Favretto S, Von Hoff DD. Gasparini G, et al. Among authors: von hoff dd. Invest New Drugs. 1991 Aug;9(3):245-52. doi: 10.1007/BF00176977. Invest New Drugs. 1991. PMID: 1783524 Clinical Trial.

5

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics.

Von Hoff DD, Turner J. Von Hoff DD, et al. Invest New Drugs. 1991 Feb;9(1):115-22. doi: 10.1007/BF00194562. Invest New Drugs. 1991. PMID: 1827432

6

A phase I clinical and pharmacokinetic trial of hepsulfam.

Ravdin PM, Havlin KA, Marshall MV, Brown TD, Koeller JM, Kuhn JG, Rodriguez G, Von Hoff DD. Ravdin PM, et al. Among authors: von hoff dd. Cancer Res. 1991 Dec 1;51(23 Pt 1):6268-72. Cancer Res. 1991. PMID: 1933887 Clinical Trial.

7

Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study.

Von Hoff DD, Green SJ, Neidhart JA, Fabian C, Budd T, Boyd JF, Osborne CK. Von Hoff DD, et al. Invest New Drugs. 1991 Feb;9(1):87-8. doi: 10.1007/BF00194553. Invest New Drugs. 1991. PMID: 2026487 Clinical Trial. No abstract available.

8

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Von Hoff DD, Fleming TR, Macdonald JS, Goodman PJ, Van Damme J, Brown TD, O'Rourke T, Feun LG, Keppen MD. Von Hoff DD, et al. J Biol Response Mod. 1990 Dec;9(6):584-7. J Biol Response Mod. 1990. PMID: 2127424 Clinical Trial.

9

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.

Taylor SA, Fleming T, Von Hoff DD, McCracken JD, Bukowski RM, Talley RW, Natale RB, Guy JT, Samlowski WE, Costanzi JH. Taylor SA, et al. Among authors: von hoff dd. Invest New Drugs. 1990 Feb;8(1):77-80. doi: 10.1007/BF00216928. Invest New Drugs. 1990. PMID: 2188928 Free article. Clinical Trial.

10

VM-26 in colorectal carcinoma: a Southwest Oncology Group study.

Oishi N, Fleming TR, Laufman L, Ungerleider JS, Natale RB, Einstein AB Jr, Von Hoff DD, Macdonald JS. Oishi N, et al. Among authors: von hoff dd. Invest New Drugs. 1990 Feb;8(1):93-5. doi: 10.1007/BF00216931. Invest New Drugs. 1990. PMID: 2188930 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

776 results

Search Page